August 01, 2014 article Open access CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models Cancer Research DOI: 10.1158/0008-5472.can-13-3723 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 7 stored of 1,342 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Reduced colony‐stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression 2026 British Journal of Haematology article Medicine Chronic Lymphocytic Leukemia Research Open access 0 citations Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages 2025 Immuno-Oncology Technology article Immunology and Microbiology Immune cells in cancer Open access 0 citations Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy 2023 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immune cells in cancer Open access 39 citations Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model 2022 Gut article Medicine Pancreatic and Hepatic Oncology Research Open access 135 citations Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice 2021 Frontiers in Oncology article Medicine Radiopharmaceutical Chemistry and Applications Open access 9 citations Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel 2021 Cellular Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access 22 citations Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model 2020 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access 65 citations 7 results References 0